Publisher Correction: Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

被引：0

作者：

Shinya Tanaka

Wataru Ise

Takeshi Inoue

Ayako Ito

Chisato Ono

Yoshihito Shima

Shuhei Sakakibara

Manabu Nakayama

Kentaro Fujii

Ikuo Miura

Jafar Sharif

Haruhiko Koseki

Pandelakis A. Koni

Indu Raman

Quan-Zhen Li

Masato Kubo

Katsunori Fujiki

Ryuichiro Nakato

Katsuhiko Shirahige

Hiromitsu Araki

Fumihito Miura

Takashi Ito

Eiryo Kawakami

Yoshihiro Baba

Tomohiro Kurosaki

机构：

[1] Osaka University,Laboratory of Lymphocyte Differentiation, WPI Immunology Frontier Research Center

[2] Kyushu University,Division of Immunology and Genome Biology, Medical Institute of Bioregulation

[3] Tokyo University of Science,Division of Molecular Pathology, Research Institute for Biomedical Science

[4] Osaka University,Laboratory of Thermo

[5] Osaka University,Therapeutics for Vascular Dysfunction

[6] Kazusa DNA Research Institute,Laboratory of Immune Regulation, WPI Immunology Frontier Research Center

[7] RIKEN BioResource Research Center,Laboratory of Medical Omics Research

[8] RIKEN Center for Integrative Medical Sciences,Technology and Development Team for Mouse Phenotype Analysis

[9] Chiba University,Laboratory of Developmental Genetics

[10] Augusta University,Advanced Research Departments, Graduate School of Medicine

[11] University of Texas Southwestern Medical Center,Georgia Cancer Center

[12] RIKEN Center for Integrative Medical Sciences,Microarray Core Facility, Department of Immunology

[13] The University of Tokyo,Laboratory for Cytokine Regulation

[14] Kyushu University Graduate School of Medical Sciences,Institute of Quantitative Biosciences

[15] Kyushu University,Department of Biochemistry

[16] Medical Sciences Innovation Hub Program,Department of Artificial Intelligence Medicine, Graduate School of Medicine

[17] RIKEN,Laboratory of Lymphocyte Differentiation

[18] Chiba University,undefined

[19] RIKEN Center for Integrative Medical Sciences,undefined

来源：

Nature Immunology | 2020年 / 21卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

引用

页码：1611 / 1612

页数：1

共 50 条

[41] DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
Zhang, Xiaotian
Su, Jianzhong
Jeong, Mira
Ko, Myunggon
Huang, Yun
Park, Hyun Jung
Guzman, Anna
Lei, Yong
Huang, Yung-Hsin
Rao, Anjana
Li, Wei
Goodall, Margaret A.
NATURE GENETICS, 2016, 48 (09) : 1014 - +
[42] TET2 controls differentiation of terminally exhausted CD8 T cells
Jordan, Martha S.
Drury, Sydney
Giles, Josephine R.
Manne, Sasikanth
Huang, Hua
Chen, Zeyu
Oldridge, Derek
Wherry, E. John
Baxter, Amy E.
JOURNAL OF IMMUNOLOGY, 2021, 206
[43] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
Song, Jinming
Moscinski, Lynn
Zhang, Hailing
Zhang, Xiaohui
Hussaini, Mohammad
CANCER GENOMICS & PROTEOMICS, 2019, 16 (01) : 91 - 98
[44] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
Song, Jimning
Hussaini, Mohammad
Talha, Rashid
Zhang, Hailing
Zhang, Ling
Shao, Haipeng
Zhang, Xiaohui
Moscinski, Lynn
MODERN PATHOLOGY, 2017, 30 : 379A - 379A
[45] Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or Isolated TET2 Mutation?
Song, Jinming
Hussaini, Mohammad
Talha, Rashid
Zhang, Hailing
Zhang, Ling
Shao, Haipeng
Zhang, Xiaohui
Moscinski, Lynn
LABORATORY INVESTIGATION, 2017, 97 : 379A - 379A
[46] Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Joseph A. Fraietta
Christopher L. Nobles
Morgan A. Sammons
Stefan Lundh
Shannon A. Carty
Tyler J. Reich
Alexandria P. Cogdill
Jennifer J. D. Morrissette
Jamie E. DeNizio
Shantan Reddy
Young Hwang
Mercy Gohil
Irina Kulikovskaya
Farzana Nazimuddin
Minnal Gupta
Fang Chen
John K. Everett
Katherine A. Alexander
Enrique Lin-Shiao
Marvin H. Gee
Xiaojun Liu
Regina M. Young
David Ambrose
Yan Wang
Jun Xu
Martha S. Jordan
Katherine T. Marcucci
Bruce L. Levine
K. Christopher Garcia
Yangbing Zhao
Michael Kalos
David L. Porter
Rahul M. Kohli
Simon F. Lacey
Shelley L. Berger
Frederic D. Bushman
Carl H. June
J. Joseph Melenhorst
Nature, 2018, 558 : 307 - 312
[47] Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells
Fraietta, Joseph A.
Nobles, Christopher L.
Sammons, Morgan A.
Lundh, Stefan
Carty, Shannon A.
Reich, Tyler J.
Cogdill, Alexandria P.
Morrissette, Jennifer J. D.
DeNizio, Jamie E.
Reddy, Shantan
Hwang, Young
Gohil, Mercy
Kulikovskaya, Irina
Nazimuddin, Farzana
Gupta, Minnal
Chen, Fang
Everett, John K.
Alexander, Katherine A.
Lin-Shiao, Enrique
Gee, Marvin H.
Liu, Xiaojun
Young, Regina M.
Ambrose, David
Wang, Yan
Xu, Jun
Jordan, Martha S.
Marcucci, Katherine T.
Levine, Bruce L.
Garcia, K. Christopher
Zhao, Yangbing
Kalos, Michael
Porter, David L.
Kohli, Rahul M.
Lacey, Simon F.
Berger, Shelley L.
Bushman, Frederic D.
June, Carl H.
Melenhorst, J. Joseph
NATURE, 2018, 558 (7709) : 307 - +
[48] Dnmt3a and Tet2 interact to Repress differentiation lineage-specific transcriptional factors in Hematopoietic Stem Cells By the Regulation of Epigenome
Zhang, Xiaotian
Jeong, Mira
Su, Jianzhong
Ko, Myung Gon
Huang, Yun
Park, Hyun Jung
Rao, Anjana
Li, Wei
Goodell, Margaret A.
BLOOD, 2014, 124 (21)
[49] TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma
Schwartz, Friederike H.
Cai, Qian
Fellmann, Eva
Hartmann, Sylvia
Mayranpaa, Mikko I.
Karjalainen-Lindsberg, Marja-Liisa
Sundstrom, Christer
Scholtysik, Rene
Hansmann, Martin-Leo
Kueppers, Ralf
JOURNAL OF PATHOLOGY, 2017, 242 (02): : 129 - 133
[50] Down-regulation of TET2 in CD3+ and CD34+ cells of myelodysplastic syndromes and enhances CD34+ cells proliferation
Zhang, Wei
Shao, Zonghong
Fu, Rong
Wang, Huaquan
Li, Lijuan
Liu, Hui
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 10840 - 10846

← 1 2 3 4 5 →